Increased plasma periostin concentration predicts angiographic vasospasm development in non-severe aneurysmal subarachnoid hemorrhage

[1]  Fumi Nakano,et al.  Anti-Apoptotic Effects of AMPA Receptor Antagonist Perampanel in Early Brain Injury After Subarachnoid Hemorrhage in Mice , 2023, Translational stroke research.

[2]  S. Safaei,et al.  Periostin: biology and function in cancer , 2022, Cancer Cell International.

[3]  H. Suzuki How to Promote Hemoglobin Scavenging or Clearance and Detoxification in Hemorrhagic Stroke , 2022, Translational Stroke Research.

[4]  Fumihiro Kawakita,et al.  Neuroelectric Mechanisms of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage , 2022, International journal of molecular sciences.

[5]  Fumi Nakano,et al.  Clarithromycin Ameliorates Early Brain Injury After Subarachnoid Hemorrhage via Suppressing Periostin-Related Pathways in Mice , 2021, Neurotherapeutics.

[6]  Masato Shiba,et al.  Cerebrovascular pathophysiology of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. , 2020, Histology and histopathology.

[7]  Fumihiro Kawakita,et al.  Potential roles of matricellular proteins in stroke , 2019, Experimental Neurology.

[8]  Hideki Kanamaru,et al.  Potential therapeutic molecular targets for blood-brain barrier disruption after subarachnoid hemorrhage , 2019, Neural regeneration research.

[9]  F. Ishida,et al.  Machine Learning Analysis of Matricellular Proteins and Clinical Variables for Early Prediction of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage , 2019, Molecular Neurobiology.

[10]  Y. Miura,et al.  Plasma Periostin and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage , 2019, Neurotherapeutics.

[11]  Lei Liu,et al.  Tenascin‐C in brain injuries and edema after subarachnoid hemorrhage: Findings from basic and clinical studies , 2018, Journal of neuroscience research.

[12]  Y. Miura,et al.  Dose-Dependent Inhibitory Effects of Cilostazol on Delayed Cerebral Infarction After Aneurysmal Subarachnoid Hemorrhage , 2018, Translational Stroke Research.

[13]  Hirofumi Nishikawa,et al.  Matricellular proteins as possible biomarkers for early brain injury after aneurysmal subarachnoid hemorrhage , 2018, Neural regeneration research.

[14]  Jiliang Hu,et al.  Increased concentration of serum periostin is associated with poor outcome of patients with aneurysmal subarachnoid hemorrhage , 2018, Journal of clinical laboratory analysis.

[15]  Lei Liu,et al.  Selective Toll-Like Receptor 4 Antagonists Prevent Acute Blood-Brain Barrier Disruption After Subarachnoid Hemorrhage in Mice , 2018, Molecular Neurobiology.

[16]  R. Macdonald,et al.  Neuroinflammation as a Target for Intervention in Subarachnoid Hemorrhage , 2018, Front. Neurol..

[17]  Hirofumi Nishikawa,et al.  Possible Role of Inflammation and Galectin-3 in Brain Injury after Subarachnoid Hemorrhage , 2018, Brain sciences.

[18]  Lei Liu,et al.  Effects of Toll-Like Receptor 4 Antagonists Against Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage in Mice , 2017, Molecular Neurobiology.

[19]  K. Izuhara,et al.  Periostin in inflammation and allergy , 2017, Cellular and Molecular Life Sciences.

[20]  G. Wong,et al.  Neuroinflammation responses after subarachnoid hemorrhage: A review , 2017, Journal of Clinical Neuroscience.

[21]  Lei Liu,et al.  Role of Periostin in Early Brain Injury After Subarachnoid Hemorrhage in Mice , 2017, Stroke.

[22]  Hidenori Suzuki,et al.  Higher Cerebrospinal Fluid pH may Contribute to the Development of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage , 2017, Translational Stroke Research.

[23]  Takeshi Okada,et al.  Toll-like receptor 4 as a possible therapeutic target for delayed brain injuries after aneurysmal subarachnoid hemorrhage , 2017, Neural regeneration research.

[24]  H. Fujishima,et al.  The usefulness of measuring tear periostin for the diagnosis and management of ocular allergic diseases. , 2016, The Journal of allergy and clinical immunology.

[25]  F. Heppner,et al.  Intravascular Inflammation Triggers Intracerebral Activated Microglia and Contributes to Secondary Brain Injury After Experimental Subarachnoid Hemorrhage (eSAH) , 2016, Translational Stroke Research.

[26]  M. Ebisawa,et al.  Periostin as a biomarker for the diagnosis of pediatric asthma , 2016, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[27]  G. E. Vates,et al.  Aneurysmal Subarachnoid Hemorrhage and Neuroinflammation: A Comprehensive Review , 2016, International journal of molecular sciences.

[28]  W. Wang,et al.  High‐level expression of periostin is significantly correlated with tumour angiogenesis and poor prognosis in osteosarcoma , 2016, International journal of experimental pathology.

[29]  T. Kawano,et al.  Characteristics of Cerebrovascular Injury in the Hyperacute Phase After Induced Severe Subarachnoid Hemorrhage , 2015, Translational Stroke Research.

[30]  T. Darsaut,et al.  Cerebral Vasospasm: A Review , 2015, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[31]  S. Quirce,et al.  Sputum periostin in patients with different severe asthma phenotypes , 2015, Allergy.

[32]  T. Betsuyaku,et al.  Phenotype of asthma related with high serum periostin levels. , 2015, Allergology international : official journal of the Japanese Society of Allergology.

[33]  Hong Zheng,et al.  Periostin, a multifunctional matricellular protein in inflammatory and tumor microenvironments. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[34]  A. Rabinstein,et al.  Extent of acute hydrocephalus after subarachnoid hemorrhage as a risk factor for poor functional outcome , 2013, Neurological research.

[35]  S. Adler,et al.  Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[36]  E. Wijdicks,et al.  Timing of clinical grade assessment and poor outcome in patients with aneurysmal subarachnoid hemorrhage. , 2012, Journal of neurosurgery.

[37]  Y. Taniyama,et al.  Role of Central Nervous System Periostin in Cerebral Ischemia , 2012, Stroke.

[38]  John H. Zhang,et al.  Mitogen-activated protein kinases in cerebral vasospasm after subarachnoid hemorrhage: a review. , 2011, Acta neurochirurgica. Supplement.

[39]  Joseph P Broderick,et al.  Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group , 2010, Stroke.

[40]  B. Conley,et al.  Vascular Injury Induces Expression of Periostin: Implications for Vascular Cell Differentiation and Migration , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[41]  Yunling E. Du,et al.  Effect of Cisternal and Ventricular Blood on Risk of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage:: The Fisher Scale Revisited , 2001, Stroke.